osteopontin inhibiting antisense oligonucleotides (NICHD)

N/A

Report date: 2025/03/20 14:43:42
NME

Base Information

Drug Nameosteopontin inhibiting antisense oligonucleotides (NICHD)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionOsteopontin antagonists
TargetsOsteopontin
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEunice Kennedy Shriver Institute Of Child Health And Human Development
China Registration ClassN/A

Develop Information

Active CompaniesEunice Kennedy Shriver Institute Of Child Health And Human DevelopmentNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsCoronary Restenosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A